Harvest Technologies Announces Interim Study Results From Critical Limb Ischemia Trial In Chennai India

Harvest Technologies Corp. (http://www.harvesttech.com) announced that the interim study report was completed for the first thirty (30) patients in the clinical trial of patients suffering with non-reconstructable critical limb ischemia due to advanced thromboangitis obliterans, commonly referred to as Buerger’s Disease.

More: continued here

Filed under: Cardiovascular on April 3rd, 2009